DC
CYTK icon

Deere & Company’s Cytokinetics CYTK Stock Holding History

Deere & Company’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-72,880
Closed -$552K – 998
2013
Q3 		$552K Buy
+72,880
New +$782K 0.03% 608

Other funds holding CYTK

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LPLP
Lansdowne Partners Limited Partnership London, United Kingdom $11.9B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
IIM
Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

Deere & Company's CYTK Position: Q4 2013 in Review

Deere & Company sold out of Cytokinetics (CYTK) in Q4 2013, closing a stake of 72,880 shares — an estimated $552K sold.

Deere & Company first reported a position in CYTK in Q3 2013 and held it in 1 quarter. The position peaked at $552K in Q3 2013. 95 funds tracked by Wall St. Rank hold CYTK as of Q4 2013.

  • Deere & Company reported no remaining Cytokinetics position as of Q4 2013 after selling out during the quarter.
  • Deere & Company sold 72,880 Cytokinetics shares in Q4 2013, an estimated $552K.
  • Deere & Company first reported a position in Cytokinetics in Q3 2013 and held it in 1 quarter.
  • Deere & Company's Cytokinetics position peaked at $552K in Q3 2013.
  • 95 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2013.

Based on Deere & Company's 13F filing for Q4 2013, filed 11 Feb 2014.